| Status: Medicine does not meet criteria for AWMSG assessment | |
Excluded from appraisal by AWMSG as meets exclusion criteria 17. See AWMSG criteria for appraising a medicine (PDF, 430Kb) for information. |
|
Medicine details |
|
| Medicine name | ropivacaine hydrochloride monohydrate (Ropivacaine®) |
| Formulation | 2 mg/ml solution for infusion |
| Reference number | 3810 |
| Indication | Acute, postoperative pain management in adults. Ropivacaine is used: to maintain a continuous peripheral nerve block via a continuous infusion, and for continuous wound infiltration |
| Company | Galen Ltd |
| BNF chapter | Anaesthesia |
| Assessment type | N/A |
| Status | Medicine does not meet criteria for AWMSG assessment |
| Date of issue | 13/07/2018 |